Address
Johnson & Johnson Development Corp Inc
410 George Street
New Brunswick, NJ 08933
United States
Phone
Website
Recent investment activity
KANDO id: 1964
Corporate information
Official name
Johnson & Johnson Innovation LLC
Also known as
JJDC Inc
Johnson & Johnson Development Corp Inc
Registration country
Company type
Accelerator of early-stage innovation worldwide that forms collaborations between entrepreneurs and Johnson & Johnson’s global healthcare businesses.Relation
Funding rounds
Investment preferences
Top investment portfolio themes
sensors (2)
medical devices (2)
Investment activity status
Active investor
Selected investments
Displaying 1 - 25 of 83Company | Profile | Country | Date | Funding | ||
---|---|---|---|---|---|---|
Allos Therapeutics Inc | N/A | |||||
Archus Orthopedics Inc | Spinal and orthopedic implant and instrument company. | Series C | ||||
Astute Medical Inc | Dedicated to improving the diagnosis of high-risk medical conditions and diseases through the identification and validation of protein biomarkers | Series C | ||||
Astute Medical Inc | Dedicated to improving the diagnosis of high-risk medical conditions and diseases through the identification and validation of protein biomarkers | Series B | ||||
ATI Medical Inc | N/A | |||||
Atrionix Inc | N/A | |||||
Axial Biotech Inc | Series B | |||||
Axya Medical Inc | N/A | |||||
BioCryst Pharmaceuticals Inc | N/A | |||||
BioRexis Pharmaceutical Corp | Series B | |||||
Cardiac Dimensions Inc | Medical device company developing novel interventional tools for the treatment of heart failure & the related condition of mitral valve regurgitation. | N/A | ||||
Cardio Polymers Inc | Biopharmaceutical company focused on non-destructive treatments for cardiac conduction abnormalities. | N/A | ||||
Catalyst Biosciences Inc | Developer of catalytic biopharmaceutical products based on engineered human proteases. | Series C | ||||
Celladon Corp | N/A | |||||
Centocor Inc | Acquisition | |||||
CoAxia Inc | A medical device company that researches therapy and treatment solutions for cerebral ischemia | Series D | ||||
Collabrys Inc | Technology-based marketing solutions company. | Series B | ||||
Critical Therapeutics Inc | Discoverer, developer and commercialize novel therapies. | N/A | ||||
Cyrano Sciences Inc | Electronic nose for homeland defense applications | N/A | ||||
Delsys Pharmaceutical Corp | Develops technology for drug development and manufacture. | N/A | ||||
Digirad Corp | Solid-state gamma cameras company for nuclear cardiology and general nuclear medicine applications. | N/A | ||||
Five Prime Therapeutics Inc | N/A | |||||
Genocea Biosciences Inc | Series B | |||||
GetWellNetwork Inc | N/A | |||||
Immunicon Corp | Biotechnology company specializing in cell-based research and diagnostic products with an initial focus on cancer. | N/A |
Pagination
Team
Employee | Position | |||
---|---|---|---|---|
Roger J Guidi | Vice President
Venture Investments |
|||
Carol A Marino | Vice President
Venture Investments |
|||
Richard V McCloskey | [email protected] | |||
Brad H Vale | Vice President
Venture Investments |
|||
Zeev Zehavi | Vice President
Venture Investments |
[email protected] | ||
Dana Gelbaum | ||||
David P Holveck | ||||
Asish K Xavier |